PEN News and Press, Penumbra Inc. From 11/06/22

Penumbra, Inc. (PEN) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET Company Participants Jee Hamlyn-Harris – Investor Relations Adam Elsesser – Chairman and Chief Executive Officer Sandra Lesenfants – President-Interventional ...

Cit has upgraded Penumbra ( NYSE: PEN ) to buy from neutral citing management expectations that it can achieve $1B in revenue in 2023 with the launches of the Thunderbolt, Lightning Bolt, and Lightning Flash devices. However, the firm lowered its price target to $212 from ...

Penumbra press release ( NYSE: PEN ): Q3 Non-GAAP EPS of $0.01 in-line. Revenue of $213.7M (+12.4% Y/Y) beats by $1.38M . For further details see: Penumbra Non-GAAP EPS of $0.01 in-line, revenue of $213.7M beats by $1.38M

Penumbra, Inc. Reports Third Quarter 2022 Financial Results PR Newswire ALAMEDA, Calif. , Nov. 3, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today reported financial results for the third ...

Summary A 3-5 month prospect from here of PEN share prices could reasonably range from a $162 low to a $196 high from its present price of $162, a +21% gain. 28 positions like today’s in the past 5 years of 1,261 market days earned average net gains at 14.7% each during 40 ...

Summary Having suffered through a sharp decline in earnings multiples, SMID cap growth stocks held up well in a volatile quarter marked by a sharp upward ratcheting of interest rates. The Strategy underperformed its benchmark, primarily due to weakness among health care holdings t...

Penumbra, Inc. to Present at the Jefferies London Healthcare Conference PR Newswire ALAMEDA, Calif. , Nov. 1, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Jefferies London Healthca...

Summary Having suffered through a sharp decline in earnings multiples, small cap growth stocks held up well in a volatile quarter marked by a sharp upward ratcheting of interest rates. The Strategy underperformed its benchmark, primarily due to weakness among health care holdings ...

SYDNEY, Australia, Oct. 24, 2022 (GLOBE NEWSWIRE) -- Omniscient Neurotechnology , the brain mapping company creating new possibilities in brain health, today announced the appointment of Barbara Nelson and Surbhi Sarna to its board of directors. Both appointees are visionaries...

Penumbra, Inc. Schedules Third Quarter 2022 Earnings Release and Conference Call for November 3, 2022 PR Newswire ALAMEDA, Calif. , Oct. 6, 2022 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss fina...